Diabetes

SAN DIEGO The developer of a wireless mobile application designed to help manage diabetes announced that its program, which is downloaded every 29 seconds worldwide, is teaming up with a mobile phone manufacturer.

MISSISSAUGA, Ontario A new study conducted by University of Toronto researchers found that GLP-1 analogues not only help to lower blood-glucose levels, but also have the added benefit of reducing body mass index and waist circumference.

WASHINGTON Two companies announced the integration of their respective programs to develop an end-to-end wireless diabetes management solution.

CLEVELAND The CEO of drug maker Eli Lilly has called for a “wave of invention” to combat diabetes.

Speaking at the Cleveland Clinic Medical Innovation Summit, John Lechleiter said breakthroughs against the disease are needed as urgently today as a century ago, noting that the disease could create a “health and economic time bomb,” as 1-in-3 Americans are forecasted to have the disease by 2050.

RALEIGH, N.C. A nonprofit that seeks to improve the health and quality of life of women with — and those at risk of developing — diabetes has kicked off a national campaign.

DiabetesSisters said that its OrangeWill campaign represents the will and determination required for women to manage their diabetes on top of their many other responsibilities.

DANBURY, Conn. The Food and Drug Administration has turned down an application for an insulin product made by Biodel, Biodel said.

The drug maker announced that it received a complete response letter from the FDA for Linjeta (human insulin [rDNA origin]) for the treatment of Type 1 and Type 2 diabetes.